Home
/
VERACYTE, INC.
/
Financials
/
Quarterly
VERACYTE, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that VERACYTE, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2018
$23.47M
Oct 29, 2018
Q3
2018
Sep 30, 2017
$17.52M
Oct 29, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$131.87M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$130.16M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$114.47M
May 8, 2025
Q3
2025
Sep 30, 2024
$115.86M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$114.43M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$96.84M
May 8, 2025
Q3
2024
Sep 30, 2023
$90.11M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$90.32M
Aug 7, 2024
Q1
2023
Jun 30, 2023
$90.32M
Aug 9, 2023
Q1
2024
Mar 31, 2023
$82.42M
May 8, 2024
Q3
2023
Sep 30, 2022
$75.59M
Nov 8, 2023
Q1
2023
Jun 30, 2022
$72.86M
Aug 9, 2023
Q2
2022
Jun 30, 2022
$72.86M
Aug 3, 2022
Q1
2023
Mar 31, 2022
$67.78M
May 5, 2023
Q3
2022
Sep 30, 2021
$60.37M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$55.11M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$36.70M
May 4, 2022
Q3
2021
Sep 30, 2020
$31.12M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$20.70M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$31.12M
May 10, 2021
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$22.75M
Jul 23, 2018
Q1
2018
Mar 31, 2018
$20.04M
May 1, 2018
Q3
2017
Sep 30, 2017
$17.52M
Nov 7, 2017
Q2
2018
Jun 30, 2017
$18.41M
Jul 23, 2018
Q1
2018
Mar 31, 2017
$16.43M
May 1, 2018
Q3
2017
Sep 30, 2016
$18.60M
Nov 7, 2017
Q2
2017
Jun 30, 2016
$14.68M
Jul 31, 2017
Q1
2017
Mar 31, 2016
$13.55M
May 3, 2017
Q3
2016
Sep 30, 2015
$12.34M
Nov 3, 2016
Q2
2016
Jun 30, 2015
$11.91M
Aug 3, 2016
Q1
2016
Mar 31, 2015
$11.22M
May 5, 2016
Q3
2015
Sep 30, 2014
$9.84M
Nov 5, 2015
Q2
2015
Jun 30, 2014
$8.68M
Aug 13, 2015
Q1
2015
Mar 31, 2014
$7.48M
May 15, 2015
Q3
2014
Sep 30, 2013
$5.59M
Nov 13, 2014
Q2
2014
Jun 30, 2013
$5.07M
Aug 14, 2014
Q1
2014
Mar 31, 2013
$4.38M
May 9, 2014
Q3
2013
Sep 30, 2012
$3.22M
Nov 25, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$19.14M
Nov 5, 2025
Q2
2025
Jun 30, 2025
($980.0K)
Aug 7, 2025
Q1
2025
Mar 31, 2025
$7.05M
May 8, 2025
Q3
2025
Sep 30, 2024
$15.16M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$5.73M
Aug 7, 2025
Q1
2025
Mar 31, 2024
($1.86M)
May 8, 2025
Q3
2024
Sep 30, 2023
($29.62M)
Nov 7, 2024
Q1
2023
Jun 30, 2023
($8.40M)
Aug 9, 2023
Q2
2024
Jun 30, 2023
($8.40M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($8.09M)
May 8, 2024
Q3
2023
Sep 30, 2022
($8.72M)
Nov 8, 2023
Q2
2022
Jun 30, 2022
($9.53M)
Aug 3, 2022
Q1
2023
Jun 30, 2022
($9.53M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($14.46M)
May 5, 2023
Q3
2022
Sep 30, 2021
($14.13M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($9.04M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($41.87M)
May 4, 2022
Q3
2021
Sep 30, 2020
($4.12M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($11.03M)
Jul 29, 2021
Q1
2021
Mar 31, 2020
($11.72M)
May 10, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$22.95M
Nov 5, 2025
Q2
2025
Jun 30, 2025
($5.27M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
$2.90M
May 8, 2025
Q3
2025
Sep 30, 2024
$12.02M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$4.61M
Aug 7, 2025
Q1
2025
Mar 31, 2024
($4.66M)
May 8, 2025
Q3
2024
Sep 30, 2023
($31.74M)
Nov 7, 2024
Q1
2023
Jun 30, 2023
($8.05M)
Aug 9, 2023
Q2
2024
Jun 30, 2023
($8.05M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($10.50M)
May 8, 2024
Q3
2023
Sep 30, 2022
($9.68M)
Nov 8, 2023
Q1
2023
Jun 30, 2022
($10.73M)
Aug 9, 2023
Q2
2022
Jun 30, 2022
($10.73M)
Aug 3, 2022
Q1
2023
Mar 31, 2022
($15.25M)
May 5, 2023
Q3
2022
Sep 30, 2021
($16.68M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($7.47M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($45.42M)
May 4, 2022
Q3
2021
Sep 30, 2020
($4.07M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($11.05M)
Jul 29, 2021
Q1
2021
Mar 31, 2020
($12.20M)
May 10, 2021